Metabolic profiles of propofol and fospropofol: clinical and forensic interpretative aspects

RJ Dinis-Oliveira - BioMed research international, 2018 - Wiley Online Library
Propofol is an intravenous short‐acting anesthetic widely used to induce and maintain
general anesthesia and to provide procedural sedation. The potential for propofol …

Delayed emergence from anesthesia: what we know and how we act

M Cascella, S Bimonte, R Di Napoli - Local and Regional …, 2020 - Taylor & Francis
The emergence from anesthesia is the stage of general anesthesia featuring the patient's
progression from the unconsciousness status to wakefulness and restoration of …

Clinical importance of potential genetic determinants affecting propofol pharmacokinetics and pharmacodynamics

I Budic, T Jevtovic Stoimenov, D Pavlovic… - Frontiers in …, 2022 - frontiersin.org
Interindividual variability in response to drugs used in anesthesia has long been considered
the rule, not the exception. It is important to mention that in anesthesiology, the variability in …

[HTML][HTML] Network dynamics scale with levels of awareness

P Coppola, LRB Spindler, AI Luppi, R Adapa, L Naci… - Neuroimage, 2022 - Elsevier
Small world topologies are thought to provide a valuable insight into human brain
organisation and consciousness. However, functional magnetic resonance imaging studies …

The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing …

A Mikstacki, O Zakerska-Banaszak… - Journal of Applied …, 2017 - Springer
Abstract Propofol (2, 6-diisopropylphenol) is one of the safest and most commonly used
anaesthetic agents for intravenous general anaesthesia. However, in clinical practice, a …

The use of PBPK modeling across the pediatric age range using propofol as a case

R Michelet, J Van Bocxlaer, K Allegaert… - … of Pharmacokinetics and …, 2018 - Springer
The project SAFEPEDRUG aims to provide guidelines for drug research in children, based
on bottom-up and top-down approaches. Propofol, one of the studied model compounds …

Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report

A Bollinger, KE Hersberger… - BMC …, 2024 - Springer
Background In clinical practice, family medication history is not routinely assessed as part of
a patient's family health history (FHH). The information is self-reported and can depend on …

Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function

J Tao, S Liu, YY Zhao, L Qi, P Yan, N Wu… - Frontiers in …, 2023 - frontiersin.org
Background: Ciprofol, a novel sedative–hypnotic drug, has been approved for its use in
inducing and maintaining general anesthesia, as well as for providing sedation. Methods: In …

Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability

AL Mourão, FG de Abreu, M Fiegenbaum - European journal of drug …, 2016 - Springer
Abstract Background and Objectives Propofol is the most commonly used hypnotic
worldwide, but its effective dose varies greatly between individuals. The present study …

Association of the CYP2B6 c. 516G> T polymorphism with high blood propofol concentrations in women from northern Greece

O Mastrogianni, E Gbandi, A Orphanidis… - Drug metabolism and …, 2014 - Elsevier
Cytochrome P450 2B6 (CYP2B6) is responsible for the initial biotransformation of profol, an
extensively metabolized intravenous anesthetic. In this study we examined the effect of the …